v3.24.3
Organization and Description of Business (Details)
$ in Thousands
9 Months Ended
Sep. 30, 2024
USD ($)
segment
medicine
Dec. 31, 2023
USD ($)
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Date of incorporation May 02, 2018  
Number of approved medicines | medicine 3  
Number of operating segments | segment 1  
Accumulated deficit $ (620,391) $ (556,239)
Unrestricted cash, cash equivalents and investments $ 293,800